High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

BACKGROUND: PARP-1 plays a critical role in DNA damage repair and contributes to progression of cancer. To explore the role of PARP-1 in acute myeloid leukemia (AML), we analyzed the expression of PARP-1 in AML and its relation to the clinical prognosis. Then, we investigated the efficacy and mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Li, Chenying, Jin, Jingrui, Wang, Jinghan, Huang, Jiansong, Ma, Zhixin, Huang, Xin, He, Xiao, Zhou, Yile, Xu, Yu, Yu, Mengxia, Huang, Shujuan, Yan, Xiao, Li, Fenglin, Pan, Jiajia, Wang, Yungui, Yu, Yongping, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306376/
https://www.ncbi.nlm.nih.gov/pubmed/30472087
http://dx.doi.org/10.1016/j.ebiom.2018.11.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306376/
https://www.ncbi.nlm.nih.gov/pubmed/30472087
http://dx.doi.org/10.1016/j.ebiom.2018.11.025

Ejemplares similares